tert-Butyl bromoacetate → HCID 10808808, 화합물

HRID 1416397노트

반응식

HRID 1416397 반응식
[O:1]=C1NCNC1=O.[N+:8]([C:11]1[CH:12]=[C:13]([CH:27]=[CH:28][CH:29]=1)[CH2:14][N:15]1[C:19](=[O:20])[C:18](=[O:21])[N:17]([CH2:22][C:23]([OH:25])=[O:24])[C:16]1=C)([O-:10])=[O:9].C(=O)(O)[O-].[K+].BrCC(O[C:40]([CH3:43])([CH3:42])[CH3:41])=O>CC(C)=O>[OH:20][CH:19]1[N:15]([CH2:14][C:13]2[CH:27]=[CH:28][CH:29]=[C:11]([N+:8]([O-:10])=[O:9])[CH:12]=2)[C:16](=[O:1])[N:17]([CH2:22][C:23]([O:25][C:40]([CH3:43])([CH3:42])[CH3:41])=[O:24])[C:18]1=[O:21]

참가 물질

6

반응물 4

HCID 79177tert-Butyl bromoacetateHCID 516893Potassium BicarbonateHCID 10638264HCID 10638264, 화합물HCID 21388926HCID 21388926, 화합물

생성물 1

HCID 10808808HCID 10808808, 화합물

시약·촉매·용매 1

HCID 180Acetone용매

실험 절차

The above-prepared dioxoimidazolidine product of paragraph (1) (12.5 g) and 10 g of potassium bicarbonate were suspended in 150 mL of acetone, 9 mL of tert-butyl bromoacetate was added thereto and the mixture was heated to reflux for eight hours with stirring. Insoluble matters were filtered off, the filtrate was concentrated in vacuo, the residue was dissolved in ethyl acetate and the solution was washed with water and a saturated saline solution. Then the solution was dried over sodium sulfate, ethyl acetate was evaporated therefrom and the resulting residue was purified by a silica gel column to give 12.4 g of tert-butyl 5-hydroxy-1-(3-nitrobenzyl)-2,4-dioxoimidazolidine-3-acetate.

후처리

  1. temperaturethe mixture was heated
  2. temperatureto reflux for eight hours
  3. filtrationInsoluble matters were filtered off
  4. concentrationthe filtrate was concentrated in vacuo
  5. dissolutionthe residue was dissolved in ethyl acetate
  6. washthe solution was washed with water
  7. dry with materialThen the solution was dried over sodium sulfate, ethyl acetate
  8. customwas evaporated
  9. customthe resulting residue was purified by a silica gel column

출처 및 근거

ORD 기록
ord-67eeaaa5595247a0aaffb6e74664c7c8
출처 데이터셋
uspto-grants-1999_06
특허 번호
US05912261

반응 노트

불러오는 중…